Deutsche Bank
AYTU icon

Deutsche Bank’s AYTU BioPharma AYTU Stock Holding History

Deutsche Bank’s Portfolio AYTU Stock Details AYTU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,040
Closed -$104K – 4401
2021
Q2 		$104K Buy
1,040
+351
+51% +$41.2K ﹤0.01% 4124
2021
Q1 		$105K Buy
689
+608
+751% +$96.5K ﹤0.01% 3954
2020
Q4 		$10K Buy
81
+23
+40% +$4.19K ﹤0.01% 4295
2020
Q3 		$14K Buy
58
+5
+9% +$1.28K ﹤0.01% 4154
2020
Q2 		$15K Buy
+53
New +$16K ﹤0.01% 4076

Other funds holding AYTU

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Deutsche Bank's AYTU Position: Q3 2021 in Review

Deutsche Bank sold out of AYTU BioPharma (AYTU) in Q3 2021, closing a stake of 1,040 shares — an estimated $104K sold.

Deutsche Bank first reported a position in AYTU in Q2 2020 and held it in 5 quarters. The position peaked at $105K in Q1 2021. 39 funds tracked by Wall St. Rank hold AYTU as of Q3 2021.

  • Deutsche Bank reported no remaining AYTU BioPharma position as of Q3 2021 after selling out during the quarter.
  • Deutsche Bank sold 1,040 AYTU BioPharma shares in Q3 2021, an estimated $104K.
  • Deutsche Bank first reported a position in AYTU BioPharma in Q2 2020 and held it in 5 quarters.
  • Deutsche Bank's AYTU BioPharma position peaked at $105K in Q1 2021.
  • 39 funds tracked by Wall St. Rank held AYTU BioPharma as of Q3 2021.

Based on Deutsche Bank's 13F filing for Q3 2021, filed 4 Nov 2021.